Work

The promise of molecular residual disease (MRD) testing for patients with colorectal cancer.

Year: 2025

Type: article

Source: PubMed

Authors: Tanios S Bekaii-Saab, Robert E Schoen

Institutions: Mayo Clinic Hospital, Mayo Clinic Comprehensive Cancer Center (Arizona), University of Pittsburgh

Language: English

Topic: Cancer Genomics and Diagnostics

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411977789

FWCI:

Cites:

Cited by:

Related to: 10